: Production, purchase or sale of genetically modified organisms which may cause an irreversible genetic pollution, a destruction of the biodiversity and health risks for the consumers.

» More environmental impacts by Aventis SA
» Pollutions in 2007

year

country : consequences

source

1 informations, access to subscribers

» More environmental impacts by Aventis SA
» Pollutions in 2007

Financials (15)

Lobbying & corruption (6)

Subsidy

Advertising & marketing (5)

year

financial misdemeanor

sales

income

buyback

source

2007

The laboratories Roche, BASF and Aventis were fined 8,5 million dollars in Brazil. They were accused of having formed a cartel, price agreements, market sharing and unfair competition on the market of vitamins. During second half of the Nineties, these three companies would have restricted the offer and increased the prices of the vitamins A, B2, B5 and C They would have also prevented the entry on the market of less expensive Chinese vitamins.

2006

Roche Holdings AG, BASF AG and Aventis will pay 30.5 mln usd to settle an Australian class action alleging they organised a cartel to fix the price of vitamins. The applicants in the class action, many of whom were farmers, alleged that as a result of the cartel they lost market share or paid inflated prices.

AFX

2005

Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said.

Canadian Press

2003

1,9

billion Eu€

2003

billion Eu€

Washington Post

2003

Entente sur le prix de la methionine sur le marché états-unien. Aventis verse 178 M$ pour mettre fin aux poursuites.

AOF

2003

Entente illicite; accord entre Aventis et Andrx pour qu'Andrx ne vende pas son médicament pour le coeur Cardizem à un prix inférieur à celui d'Aventis: amende de 80 et 110 millions de $US.

AOF

2002

21,66

2,28

billion US$

2002

Entente pour fixer le prix de la méthylglucamine entre 1990 et 1999: amende de 2,85 millions d'euros après réduction de 40% pour avoir collaboré lors de l'enquête.

Les Echos

2002

Accused with fraud and bribery schemes to inflate prices for consumers and government health plans.

Financial Times

2002

market-sharing and price-fixing cartels affecting vitamin products in Europe: 5,04 million euros fine.

Commission Européenne

2002

Entente sur le prix de la méthionine, échappe à l'amende pour avoir révélé cette entente.

Les Echos

2001

20,45

1,46

billion US$

2000

22,3

1,13

billion Eu€

1999

12,6

-0,97

billion Eu€

» More financial data for Aventis SA
» Financial delinquency in 2007

year

financial misdemeanor

sales

income

assets

buyback

source

15 informations, access to subscribers

» More financial data for Aventis SA
» Financial delinquency in 2007

year

purpose : intermediary/lobby : institution

source

2002

Market admission for genetically modified organisms : Europabio : : European Commission

translate

Corporate Europe Observatory

2000

Prevent binding environmental regulations (environmental protection through economic growth, self-regulation and free trade) : WBCSD (World Business Council for Sustainable Development) : : United Nations

translate

Corporate Europe Observatory

2000

Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate

translate

Washington Post

2000

Market access (through WTO), cheaper energy (through energy liberalization in Europe); uniform rules to enable the patenting of plants and animals (through TRIPS); prevent advert legislation on chemicals, self-regulation instead; : CEFIC (European Chemical Industry Council) : : European Commission

translate

Corporate Europe Observatory

2000

Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission

translate

EFPIA

2000

Access to public services (privatization through GATS) : ERT (European Roundtable of Industrialists) : : European Commission

translate

Corporate Europe Observatory

» More influence from Aventis SA
» Influence in 2007

year

purpose : intermediary/lobby : institution

source

6 informations, access to subscribers

» More influence from Aventis SA
» Influence in 2007

year

dubious practice : image

source

2002

Arguable partnership: Institut de France (Académie française, Académie des inscriptions et belles-lettres, Académie des sciences, Académie des beaux-arts, Académie des sciences morales et politiques): "Science Génération":

2001

ad budget: 167 million US$;

Advertising Age

2000

ad budget: 104 million US$;

Advertising Age

2000

Arguable partnership: Global Compact with the United Nations: value: Respects human, social and environmental laws;

ONU

1999

value: Respect de la nature; slogan: Notre challenge, c'est la vie.;

» More ads and public relations campaign from Aventis SA
» Dubious practices in 2007